InvestorsHub Logo
Followers 0
Posts 1632
Boards Moderated 0
Alias Born 03/27/2002

Re: None

Sunday, 03/02/2003 2:21:07 PM

Sunday, March 02, 2003 2:21:07 PM

Post# of 14671
appears the address of this beneficial owner of healthcare networks sol owns the domain name for novabiogenetics!! can anyone explain the relationaship that exists with ibcl and this comapny that now filed a statement of beneficial ownership with hnws and owns the domain for nova? how are they connected with ibcl?
Company Filings

HEALTHCARE NETWORK SOLUTIONS INC
Form: SC 13G Filing Date: 2/24/2003 Filing Index

SELECT FONT SIZE 1=smallest2=smaller3=larger4=largest CLICK THE 'ENTER' BUTTON


TYPE: SC 13G OTHERDOC
SEQUENCE: 1
FILENAME: schedule13gckern.txt
DESCRIPTION: SCHEDULE 13G

OTHERDOC AVAILABLE Series=schedule13gckern.txt Ver="": Document is copied.
OMB APPROVAL
OMB Number: 3235-0145
Expires: December 31, 2005
Estimated average burden
hours per response......11





UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. 1)1


Healthcare Network Solutions, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)

Warrants to purchase Issuer's $.0001 par value common stock
--------------------------------------------------------------------------------
(Title of Class of Securities)

42220D 10 7
--------------------------------------------------------------------------------
(CUSIP Number)

February 15, 2003
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)

1 In accordance with Rule 13d-3(d)

Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:

[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)


* The remainder of this cover page shall be filled out for the reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).

CUSIP No. 42220D 10 7



1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).

Christopher Kern
................................................................
--------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]

(b) [X]
--------------------------------------------------------------------------------
3. SEC Use Only

................................................................
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization
U.S.A.
................................................................
--------------------------------------------------------------------------------

5. Sole Voting Power 1,807,100 (A)
Number of Shares ----------------------------------------------
Beneficially Owned 6. Shared Voting Power -0-
by Each Reporting ----------------------------------------------
Person With 7. Sole Dispositive Power 1,807,100
----------------------------------------------
8. Shared Dispositive Power -0-
----------------------------------------------
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person

Warrant to purchase up to 1,000,000 shares of Issuer's $.0001 par value
common stock and 807,100 shares of common stock remaining from exercise
of 1,000,000 options at $.05 per share on March 26, 2002.
.......................................................................
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions)

.......................................................................
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (9)

7.84%
................................................................
--------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions)

** Shares of common stock as of November 1, 2002 22,046,062
Maximum shares to be issued upon option exercise 1,000,000
-----------
Total 23,046,062
--------------------------------------------------------------------------------
(A) Sole voting and dispositive power will only occur as to 1,000,000 if
and to the extent common shares are issued pursuant to option exercise
at $1.00 per share.

2



Item 1
(a) Name of Issuer:

Healthcare Network Solutions, Inc.
............................................................
(b) Address of Issuer's Principal Executive Offices:

8383 Dunwoody Place, Atlanta, Georgia 30350
............................................................
Item 2
(a) Name of Person Filing:

Christopher Kern
............................................................
(b) Address of Principal Business Office or, if none, Residence:

1175 Walt Whitman Road, Suite 100
Melville, New York 11747
............................................................
(c) Citizenship:

U.S.A.
............................................................
2(d) Title of Class of Securities:

Warrants to purchase up to 1,000,000 shares of Issuer's $.0001 par
value common stock and 807,100 shares of common stock remaining from
earlier exercise of 1,000,000 options. See No. 9
.......................................................................
2(e) CUSIP Number:

42220D 10 7
............................................................
Item 3 If this statement is filed pursuant toss.ss.240.13.d-1(b) or
240.13d-2(b) or (c), check whether the person filing is a:

(a) [ ] Broker or dealer registered under Section 15 of the Act
(15 U.S.C. 78c)
(b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c)
(c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act
(15 U.S.C. 78c)
(d) [ ] Investment company registered under Section 8 of the Investment
Company Act of 1940 (15 U.S.C. 80a-8)
(e) [ ] An investment adviser in accordance with
ss.240.13d-1(b)(1)(ii)(E)
(f) [ ] An employee benefit plan or endowment fund in accordance with
ss.240.13d-1(b)(1)(ii)(F)
(g) [ ] A parent holding company or control person in accordance with
ss.240.13d-1(b)(1)(ii)(G)
(h) [ ] A savings association as defined in Section 3(b) of the Federal
Deposit Insurance Act (12 U.S.C. 1813)

3



(i) [ ] A church plan that is excluded from the definition of an
investment company under Section 3(C)(14) of the Investment
Company Act of 1940 (15 U.S.C. 80a-3)
(j) [ ] Group, in accordance withss.240.13d-1(b)(1)(ii)(J)

Item 4 Ownership

Provide the following information regarding the aggregate number and
percentage of the class of securities of the Issuer identified in
Item 1.

(a) Amount beneficially owned:

1,807,100 inclusive of shares underlying 1,000,000 exercisable options
to purchase a like number of Issuer's $.0001 par value common stock
which shares may be acquired in accordance with Rule 13d-3(d)(1)(i)(A)
.......................................................................

(b) Percent of Class:
7.84%
............................................................

(c) Number of shares as to which the person has:

1,807,100
............................................................

(i) Sole power to vote or to direct the vote:
1,807,100
..............................................................
(ii) Shared power to vote or to direct the vote:
-0-
..............................................................
(iii) Sole power to dispose or to direct the disposition of:

1,807,100, inclusive of 1,000,000 shares subject to presenting
exercisable options at $1.00 per share.
..............................................................
(iv) Shared power to dispose or to direct the disposition of:
-0-
..............................................................
Item 5 Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of
more than five percent of the Class of securities, check the
following [ ]

Item 6 Ownership of More than Five Percent on Behalf of Another Person

If any other person is known to have the right to receive or the power
to direct the receipt of dividends from, or the proceeds from the sale
of such securities, a statement to that effect should be included in
response to this item, and, if such interest relates to more than five
percent of the class, such person should be identified. A listing of
the shareholders of an investment company registered under the
Investment Company Act of 1940 or the beneficiaries of employee benefit
plan, pension fund or endowment fund is not required.

4


Item 7 Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company or Control
Person

If a parent holding company or Control person has filed this schedule,
pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under Item 3(g) and
attach an exhibit stating the identity and the Item 3 classification of
the relevant subsidiary. If a parent holding company or control person
has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d),
attach an exhibit stating the identification of the relevant
subsidiary.

Item 8 Identification and Classification of Members of the Group

If a group has filed this schedule pursuant to
ss.240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and
attach an exhibit stating the identity and Item 3 classification of
each member of the group. If a group has filed this schedule pursuant
to ss.240.13d-1(c) or ss.240.13d-1(d), attach an exhibit stating the
identity of each member of the group.

Item 9 Notice of Dissolution of Group

Notice of dissolution of a group may be furnished as an exhibit stating
the date of the dissolution and that all further filings with respect
to transactions in the security reported on will be filed, if required,
by members of the group, in their individual capacity. See Item 5.

Item 10 Certification

(a) The following certification shall be included if the statement is filed
pursuant toss.240.13d-1(b):

By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were acquired and
are held in the ordinary course of business and were not
acquired and are not held for the purpose of or with the
effect of changing or influencing the control of the Issuer of
the securities and were not acquired and are not held in
connection with or as a participant in any transaction having
that purpose or effect.

(b) The following certification shall be included if the statement is filed
pursuant toss.240.13d-1(c):

By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired
and are not held for the purpose of or with the effect of
changing or influencing the control of the Issuer of the
securities and were not acquired and are not held in
connection with or as a participant in any transaction having
that purpose or effect.




5






SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.



February 14, 2003
------------------
Date
/s/ Christopher Kern
--------------------
Signature
Christopher Kern
--------------------
Name/Title


The original statement shall be signed by each person on whose behalf the
statement is filed or his authorized representative. If the statement is signed
on behalf of a person by his authorized representative other than an executive
officer or general partner of the filing person, evidence of the
representative's authority to sign on behalf of such person shall be filed with
the statement, provided, however, that a power of attorney for this purpose
which is already on file with the Commission may be incorporated by reference.
The name and any title of each person who signs the statement shall be typed or
printed beneath his signature.



NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See ss.240.13d-7 for other
parties for whom copies are to be sent.



Attention: International misstatements or omissions of fact constitute Federal
criminal violations

(See 18 U.S.C. 1001)




6


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.